Product Reports Resources Pricing Login Book a demo

Zelis

Health Tech & Medtech · Boston, United States · Founded 2016

Healthcare financial solutions optimizing payments, claims cost management, and transparency for payers, providers, and consumers

Valuation $10–50B
Revenue $1–5B
Headcount 2–5k
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Zelis and the history behind them.
Power Law Decacorn$10B+ valuation tier Thoroughbred$100M+ revenue

Talent graph

Zelis's talent

Book a demo to see the people
Employees mapped 3,028 incl. 16 AI specialists
Founders Hidden — book a demo/100 quality score
Key operators 11 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Investors

5 investors on Zelis's cap table

Sourced from Dealroom's funding and investor records. Investor profile links are shown where available.

Series B+ 5 investors entered at this stage
Norwest Venture Partners
Bain Capital
Mubadala Capital
HarbourVest Partners
Bain Capital Ventures

Global footprint

Where Zelis has talent and traffic

Workforce by country
🇺🇸 United States · Boston HQ
Book a demo for the full country breakdown
Web traffic by country
400K monthly visits
across markets
🇺🇸 United States91.1%
🇮🇳 India7.3%
🇬🇧 United Kingdom0.6%
🇨🇦 Canada0.3%
🇻🇳 Vietnam0.2%
Top 5 markets shown

Capital deployed

Zelis's 9 investments and acquisitions.

Every disclosed deal where Zelis appeared as a backer or acquirer, 2016–2026. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.

Portfolio analysis

9 deals across Zelis's capital deployment.

Where the deals concentrate by sector, stage, and decade.

By sectorCount
    By stageCount
      By periodCount

        02 · Portfolio market map

        Zelis's portfolio, mapped.

        Each chip is one company. Pill colour shows round type — green for Seed, blue for Series A, purple for B/C+, pink for late-stage, amber for M&A. Bigger sectors keep their full list behind “+ N more”.

        Stage
        Period
        9 of 9 deals

        Market sentiment

        What the market is saying about Zelis

        An AI-synthesized read of the highest-engagement posts about Zelis on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

        Reading the room on X — pulling top posts and synthesizing themes…

        Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

        See Zelis on the full Dealroom platform

        Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

        Book a demo Explore company profiles